3-Chloropropyltriethoxysilane

We are 3-Chloropropyltriethoxysilane CAS:5089-70-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Chemical Name:3-Chloropropyltriethoxysilane
CAS.NO:5089-70-3
Synonyms:3-(Triethoxysilyl)propyl Chloride; Silane, (3-chloropropyl)triethoxy-;
3-Triethoxysilyl-1-chloropropane; (3-Chloropropyl)triethoxysilane;
3-Chloropropyltriethoxsilane;
Molecular Formula:C9H21ClO3Si
Molecular Weight:240.80000
 
Physical and Chemical Properties:
Density:1.008;
Boiling point:220^oC;
Flash point:98^oC;
Index of Refraction:1.420;
 
Specification:
Appearance:Colorless clear liquid
Purity(GC):≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It reacts with silanol groups of white fillers during mixing and with halogenated polymers using suitable curing systems during vulcanization under formation of covalent chemical bonds. This imparts greater tensile strength, higher moduli, reduced compression set and increased abrasion resistance. SiSiB? PC5012 is used in combination with halogenated polymers in a variety of rubber products where silanol group-containing white fillers are used and where optimum technical properties are required.
It can be used as an intermediate for other functional organosilanes.




Related News: Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage.10-Fluorodecan-1-ol The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.2,3-dichloro-5-fluoropyridine The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.110-64-5 First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.